Blog
Home Blog
[printfriendly]
LnRiLWZpZWxke21hcmdpbi1ib3R0b206MC43NmVtfS50Yi1maWVsZC0tbGVmdHt0ZXh0LWFsaWduOmxlZnR9LnRiLWZpZWxkLS1jZW50ZXJ7dGV4dC1hbGlnbjpjZW50ZXJ9LnRiLWZpZWxkLS1yaWdodHt0ZXh0LWFsaWduOnJpZ2h0fS50Yi1maWVsZF9fc2t5cGVfcHJldmlld3twYWRkaW5nOjEwcHggMjBweDtib3JkZXItcmFkaXVzOjNweDtjb2xvcjojZmZmO2JhY2tncm91bmQ6IzAwYWZlZTtkaXNwbGF5OmlubGluZS1ibG9ja311bC5nbGlkZV9fc2xpZGVze21hcmdpbjowfQ==
LnRiLWhlYWRpbmcuaGFzLWJhY2tncm91bmR7cGFkZGluZzowfQ==
- TGF0bzo3MDAjIyNQb3BwaW5zOjMwMA==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Feb 1, 2012
Publication of Phase III Study Shows Positive Results for Diabetic Neuropathic Pain
The results of a 13-week study by Avanir Pharmaceuticals, published in the journal Pain Medicine, show efficacy and safety of AVP-923 for treatment of diabetic neuropathic pain. Currently also in… - TGF0bzo3MDAjIyNQb3BwaW5zOjMwMA==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Feb 1, 2012
Neuropathy Patients More Likely to Receive High-cost, Low-yield Screening Instead of More Effective Tests
A new study from University of Michigan researchers found that the most efficient testing is not always done for peripheral neuropathy – especially diabetes related neuropathy. Led by Dr. Brian… -
Feb 1, 2012
EpiCept Files for AmiKetâ„¢ Fast Track Designation
EpiCept Corporation announced that it has filed for Fast Track designation for AmiKet, their new topical cream to be used in the treatment of chemotherapy-induced peripheral neuropathy. The Fast Track… -
Feb 1, 2012
Fighting Off Cancer Does Cost
In a study from the Colorado Cancer Center, results have shown that using Oxaliplatin for the treatment of colorectal cancer causes Oxaliplatin-induced neurotoxicity (OXIN). One way to avoid immediate symptoms… -
Jan 1, 2012
Evolution in the Pain Therapy Drug Market: Nociceptive and Neuropathic Drug Development
With pain affecting 1.5 billion people worldwide, much work is needed to understand pain, what is currently available to treat pain, and what should be developed over the next 5… -
Jan 1, 2012
Recently Published Study Investigating Alpha Lipoic for Diabetes Resulted in General Systemic Improvement
Nutri-Med Logic Corp has taken the results of a recent published study, in the European Journal of Nutrition to report on the benefits of R-Alpha Lipoic for Diabetes. This article… -
Dec 1, 2011
Acupuncture Soothes Chemo-Induced Neuropathic Pain
According to the results of a small pilot study published in Acupuncture in Medicine, acupuncture may help relieve the severe pain associated with chemotherapy-induced peripheral neuropathy. READ MORE Source: Medscape -
Dec 1, 2011
Nerve Damage May Mask Hypothermia
Diabetic neuropathy may be an added risk for hypothermia because neuropathy can impair the body’s ability to control body temperature. Neuropathy also poses a risk for frostbite. There are several…